Can GLP-1s Affect Gambling, Shopping, and Other Compulsions?

People report that non-food compulsions quieted too. Regulators are watching a signal that runs the other way. The direct evidence is almost entirely missing.

The short answer

This is one of the most talked-about and least studied corners of the GLP-1 story. Many users report that urges beyond food — gambling, online shopping, skin-picking, nail-biting — grew quieter alongside their appetite. At the same time, drug regulators have opened reviews into whether these medications might, in some people, be associated with impulse-control problems. Both directions are being watched, and neither is established. We label this a field note, not an evidence brief, on purpose.

What people report

Analyses of social-media accounts describe reduced gambling urges, less compulsive online shopping, and diminished interest in various repetitive, reward-seeking behaviors. In one mixed-methods study of user comments, roughly a fifth described an interruption in compulsive shopping specifically. These are self-reports, filtered through who chooses to post — useful for generating hypotheses, not for estimating how common an effect really is.

What regulators are examining

The picture is not one-directional. By mid-2024, the European Medicines Agency had reviewed a safety signal concerning GLP-1 receptor agonists and impulse-control disorders, and U.S. regulators have examined the same question. A signal under review is an early flag that warrants investigation — it is not a confirmed causal finding. It does mean the honest version of this topic includes the possibility of harm in some people, not only benefit.

Why the mechanism cuts both ways

GLP-1 receptors are present throughout the mesolimbic dopamine pathway, the brain's core reward circuit. That is a plausible reason the same drug could touch many reward-driven behaviors — and also why effects might be uneven or even opposite across individuals, depending on the behavior and the person. Plausibility explains the interest; it does not settle the direction.

What this means now

There are, as of this writing, no randomized trials of GLP-1 medications for gambling or other non-food compulsions. No one should use these drugs to treat a compulsive behavior outside medical care, and anyone struggling with gambling, compulsive shopping, or similar behaviors deserves evidence-based support now. This is precisely the kind of question where careful, well-framed community data — collected without overclaiming — could help identify what is worth formal study.